Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside
- 30 December 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Vascular Pharmacology
- Vol. 19 (2), 210-232
- https://doi.org/10.2174/1570161118666200325102411
Abstract
Sleep is essential to and an integral part of life and when lacking or disrupted, a multitude of mental and physical pathologies ensue, including cardiovascular (CV) disease, which increase health care costs. Several prospective studies and meta-analyses show that insomnia, short (9h) sleep and other sleep disorders are associated with an increased risk of hypertension, metabolic syndrome, myocardial infarction, heart failure, arrhythmias, CV disease risk and/or mortality. The mechanisms by which insomnia and other sleep disorders lead to increased CV risk may encompass inflammatory, immunological, neuro-autonomic, endocrinological, genetic and microbiome perturbations. Guidelines are emerging that recommend a target of >7 h of sleep for all adults >18 years for optimal CV health. Treatment of sleep disorders includes cognitive-behavioral therapy considered the mainstay of non-pharmacologic management of chronic insomnia, and drug treatment with benzodiazepine receptor agonists binding to gamma aminobutyric acid type A (benzodiazepine and non-benzodiazepine agents) and some antidepressants. However, observational studies and meta-analyses indicate an increased mortality risk of anxiolytics and hypnotics, although bias may be involved due to confounding and high heterogeneity in these studies. Nevertheless, it seems that the risk incurred by the non-benzodiazepine hypnotic agents (Z drugs) may be relatively less than the risk of anxiolytics, with evidence indicating that at least one of these agents, zolpidem, may even confer a lower risk of mortality in adjusted models. All these issues are herein reviewed.This publication has 152 references indexed in Scilit:
- The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studiesHypertension Research, 2013
- Insomnia and the risk of incident heart failure: a population studyEuropean Heart Journal, 2013
- Cognitive Therapy Improves Three-Month Outcomes in Hospitalized Patients With Heart FailureJournal of Cardiac Failure, 2012
- The size and burden of mental disorders and other disorders of the brain in Europe 2010European Neuropsychopharmacology, 2011
- Sleep loss and inflammationBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- Association Between Sleep and Blood Pressure in MidlifeJAMA Internal Medicine, 2009
- Sleep Quality and Elevated Blood Pressure in AdolescentsCirculation, 2008
- Gender-Specific Associations of Short Sleep Duration With Prevalent and Incident HypertensionHypertension, 2007
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006